Relapse After Dupilumab Discontinuation in Pediatric Moderate-to-Severe Atopic Dermatitis: A Single-Center Retrospective Study From China. // Clinical Therapeutics. – URL: https://www.sciencedirect.com/science/article/pii/S0149291826003486?dgcid=rss_sd_all
Relapse After Dupilumab Discontinuation in Pediatric Moderate-to-Severe Atopic Dermatitis: A Single-Center Retrospective Study From China. Clinical Therapeutics. https://www.sciencedirect.com/science/article/pii/S0149291826003486?dgcid=rss_sd_all
“Relapse After Dupilumab Discontinuation in Pediatric Moderate-to-Severe Atopic Dermatitis: A Single-Center Retrospective Study From China.” Clinical Therapeutics.
@article{article41755,
title = {Relapse After Dupilumab Discontinuation in Pediatric Moderate-to-Severe Atopic Dermatitis: A Single-Center Retrospective Study From China},
journal = {Clinical Therapeutics},
url = {https://www.sciencedirect.com/science/article/pii/S0149291826003486?dgcid=rss_sd_all}
}